Global Oncolytic Virus Therapy Pipeline Analysis

Published: October 2013
No. of Pages: 105
  

Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat cancer by 2020.

The form of Oncolytic virus, which has the maximum potential in the future and is the most promising, is the reovirus. This is a non-enveloped virus with a double-stranded, segmented RNA genome which forms particles of 60 to 90 nm size. The reovirus duplicates in those cancer cells which have a common mutation called “activated Ras pathway”. The normal cells are not impacted. Thus the virus is made intrinsically tumor selective without the need for any genetic manipulation.

Global Oncolytic Virus Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various Oncolytic virus drugs being developed for the treatment of multiple cancers. Research report covers all the ongoing Oncolytic Virus drugs being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Oncolytic Virus market based upon development process.

Following parameters for each Oncolytic Virus drug profile in development phase are covered in research report:

  • Drug Profile Overview
  • Alternate Names for Drug
  • Active Indication
  • Phase of Development
  • Mechanism of Action
  • Brand Name
  • Patent Information
  • Orphan Designation by Indication, Country & Organisation
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • ATC Codes

Oncolytic Virus Drug by Clinical Phase:

  • Research: 1
  • Preclinical: 16
  • Phase-I: 6
  • Phase-I/II: 5
  • Phase-II: 5
  • Phase-III: 2
  • Registered: 1
  • Discontinued: 16

Global Oncolytic Virus Therapy Pipeline Analysis

Table of Contents

1. Oncolytic Viruses: Potential Future Cancer Therapy

2. Oncolytic Virus Therapy Clinical Phase: Research
2.1 Overview
2.2 Drug Profiles in Clinical Phase

3. Oncolytic Virus Therapy Clinical Phase: Preclinical
3.1 Overview
3.2 Drug Profiles in Clinical Phase

4. Oncolytic Virus Therapy Clinical Phase: Phase-I
4.1 Overview
4.2 Drug Profiles in Clinical Phase

5. Oncolytic Virus Therapy Clinical Phase: Phase-I/II
5.1 Overview
5.2 Drug Profiles in Clinical Phase

6. Oncolytic Virus Therapy Clinical Phase: Phase-II
6.1 Overview
6.2 Drug Profiles in Clinical Phase

7. Oncolytic Virus Therapy Clinical Phase: Phase-III
7.1 Overview
7.2 Drug Profiles in Clinical Phase

8. Oncolytic Virus Therapy Clinical Phase: Registered
8.1 Overview
8.2 Drug Profiles in Clinical Phase

9. Discontinued Oncolytic Virus Profiles
9.1 Overview
9.2 Drug Profiles

List of Tables and Figures

Each Drug Profile has Tables Representing Following Information:

Alternate Names
Originator & Owner
Collaborator
Technology Provider
Licensee(s)
Highest Development Phase
Indications
Class
Mechanism of Action
WHO & EphMRA ATC code
Designated Brand Name & Orphan Designation

Published By: PNS Pharma
Product Code: PNS Pharma3


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 400,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100